Testing effectiveness (Phase 2)Study completedNCT00988143What this trial is testingInfluenza Virus Vaccines in Children and AdultsWho this might be right forInfluenza Sanofi Pasteur, a Sanofi Company 600
Large-scale testing (Phase 3)Study completedNCT00232947What this trial is testingStudy Comparing Immune Response to, and Safety of, Fluviral and Fluzone Influenza Vaccines in Persons 50 y.o. and OverWho this might be right forInfluenza ID Biomedical Corporation, Quebec 900
Not applicableStudy completedNCT04568785What this trial is testingEffectiveness of a Brief Intervention for Acceptance of Influenza Vaccine in the Primary Care SettingWho this might be right forInfluenza VaccinationHealth Education Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 524
Early research (Phase 1)Study completedNCT00868218What this trial is testingStudy of a Parenterally Administered H5N1 Influenza Vaccine in Healthy AdultsWho this might be right forInfluenzaHealthy Rebecca Cox 60
Large-scale testing (Phase 3)Study completedNCT01389518What this trial is testingEfficacy and Safety of Paracetamol, Chlorpheniramine and Phenylephrine in the Treatment of Common Cold and Flu SyndromeWho this might be right forFlu Hospital de Clinicas de Porto Alegre 146
Large-scale testing (Phase 3)Study completedNCT02218697What this trial is testingEvaluation of the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine Influsplit™ Tetra (Fluarix™ Tetra) (GSK2321138A) When Co-administered With Pneumovax™ 23 in Adults 50 Years of Age and OlderWho this might be right forInfluenza GlaxoSmithKline 357
Not applicableNot Yet RecruitingNCT07430410What this trial is testingClinical Validation of an At-Home Flu A/B and COVID-19 Rapid TestWho this might be right forSARS-CoV-2 InfectionInfluenza AInfluenza B CorDx, Inc. 200
Early research (Phase 1)Ended earlyNCT02014168What this trial is testingSafety and Immunogenicity of Co-administration of Candidate Influenza Vaccine MVA-NP+M1 and Viroflu® Seasonal Influenza VaccineWho this might be right forInfluenza University of Oxford 3
Testing effectiveness (Phase 2)Study completedNCT00966238What this trial is testingSafety and Immunogenicity of VAX125 Influenza Vaccine in Community-living Adults >= 65 Years of AgeWho this might be right forInfluenza VaxInnate Corporation 120
Not applicableStudy completedNCT07254052What this trial is testingEffectiveness of Ammonium Chloride in Reducing Viral LoadWho this might be right forRNA Virus InfectionsViral Infection COVID-19Influenza A and B National and Kapodistrian University of Athens 32
Not applicableUnknownNCT01247415What this trial is testingClinical Investigation on Allergic-like Reactions and Oculo-respiratory Syndrome After the H1N1 Pandemic VaccineWho this might be right forAnaphylaxisAllergyOculorespiratory Syndrome+1 more PHAC/CIHR Influenza Research Network 138
Post-approval studies (Phase 4)Study completedNCT01430689What this trial is testingMaternal Flu Vaccine Trial in Bamako, MaliWho this might be right forInfluenza University of Maryland, Baltimore 4,193
Not applicableEnrolling By InvitationNCT07673250What this trial is testingPersonalized Ventilator Settings for Patients on ECMOWho this might be right forAcute Respiratory Distress Syndrome (ARDS)Extracorporeal Membrane OxygenationRespiratory Failure Patients Treated With ECMO+2 more University of California, San Diego 62
Large-scale testing (Phase 3)Study completedNCT01459952What this trial is testingA Double-blind, Randomised, Parallel Group,Comparative Study With Rose-hip Liquid and Placebo Given to Healthy Volunteers in the Winter Season Aiming to Evaluate the Occurences of Flu and Catching a ColdWho this might be right forFluCommon Cold Hyben Vital ApS 120
Large-scale testing (Phase 3)Looking for participantsNCT05624450What this trial is testingEfficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental OxygenWho this might be right forViral Lung Infection and Acute Respiratory Failure AstraZeneca 3,527
Large-scale testing (Phase 3)WithdrawnNCT04139915What this trial is testingEffect of RTB101 on Illness Associated With Respiratory Tract Infections in the ElderlyWho this might be right forClinically Symptomatic Respiratory Illness Restorbio Inc.
Testing effectiveness (Phase 2)WithdrawnNCT00962715What this trial is testingReactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia M.D. Anderson Cancer Center
Not applicableLooking for participantsNCT07431840What this trial is testingImmune Defense Protein Impact On Respiratory Immune OutcomesWho this might be right forUpper Respiratory DiseaseInfluenzaViral Upper Respiratory Infection Quantec Ltd 300
Early research (Phase 1)Study completedNCT05152017What this trial is testingThe Objectives of This Study Are Study the Safety, Reactogenicity and Obtain Preliminary Data on the Immunogenicity of Flu-M Quadro, 4-valent Inactivated Split Influenza Vaccine, in Healthy VolunteersWho this might be right forInfluenza St. Petersburg Research Institute of Vaccines and Sera 75
Testing effectiveness (Phase 2)Study completedNCT00900991What this trial is testingSafety and Immunogenicity of a Split-Virion Pandemic Influenza A (H5N1) Vaccine in ChildrenWho this might be right forInfluenza Sinovac Biotech Co., Ltd